Sphingolipids in Alzheimer's Disease and Related Disorders

J Alzheimers Dis. 2017;60(3):753-756. doi: 10.3233/JAD-170735.

Authors

Pilar Martinez Martinez¹, Michelle M Mielke²

Affiliations

¹ Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
² Division of Epidemiology, Department of Health Sciences Research, and the Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.

PMID: 28922162
DOI: 10.3233/JAD-170735

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Alzheimer Disease / metabolism*
Amyloid beta-Peptides
Biomarkers / blood
Biomarkers / cerebrospinal fluid
Humans
Sphingolipids / metabolism*

Substances

Amyloid beta-Peptides
Biomarkers
Sphingolipids